Centrient Pharmaceuticals Netherlands B.V. – Trademark Portfolio
Entity Type: 98
Centrient Pharmaceuticals Netherlands B.V. holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 12 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered and 3 are pending. Notable registered marks include PURIMOX and PURIDROX.
Alexander Fleminglaan 1
NL-2613 AX Delft
Showing of trademarks Trademarks
Trademark Classifications
Centrient Pharmaceuticals Netherlands B.V.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Centrient Pharmaceuticals Netherlands B.V. have?
Centrient Pharmaceuticals Netherlands B.V. has 12 U.S. trademarks filed with the USPTO. Of these, 2 registered, 3 pending, 1 abandoned, 2 cancelled.
What trademark classes does Centrient Pharmaceuticals Netherlands B.V. file in?
Centrient Pharmaceuticals Netherlands B.V. files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Centrient Pharmaceuticals Netherlands B.V.'s most well-known trademarks?
Centrient Pharmaceuticals Netherlands B.V.'s registered trademark portfolio includes well-known marks such as PURIMOX and PURIDROX. These are among 2 currently registered trademarks in the portfolio.
What is Centrient Pharmaceuticals Netherlands B.V.'s trademark registration success rate?
Centrient Pharmaceuticals Netherlands B.V. has a 40% trademark registration rate, with 2 out of 5 resolved applications resulting in successful registration. Currently, 3 applications are pending review.